SCHEMBL15912858

SCHEMBL15912858

CC(C)Oc1cc(-c2cnc(N)cn2)ccc1Cl

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5AP P20292 7/20 0.51
FEN1 P39748 6/20 0.51
DYRK1A Q13627 1/20 0.43
KMO O15229 3/20 0.41
MAP4K4 O95819 1/20 0.41
SLC6A2 P23975 2/20 0.41
SLC6A4 P31645 2/20 0.41
SLC6A3 Q01959 2/20 0.41
PIK3CD O00329 1/20 0.41
PIK3CA P42336 1/20 0.41
PIK3CB P42338 1/20 0.41
PIK3CG P48736 1/20 0.41
TRPV1 Q8NER1 1/20 0.41
TLR9 Q9NR96 2/20 0.39
TLR8 Q9NR97 2/20 0.39
TLR7 Q9NYK1 2/20 0.39
JAK2 O60674 2/20 0.38
JAK1 P23458 1/20 0.38
TYK2 P29597 1/20 0.38
JAK3 P52333 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11372102 0.78 KMO (0.59) ALOX5APFEN1KMOSLC6A2SLC6A4
SCHEMBL15912919 0.76 ALOX5AP (0.69) ALOX5APFEN1MAP4K4PIK3CDPIK3CA
SCHEMBL13728902 0.75 ALOX5AP (0.46) ALOX5APFEN1MAP4K4
SCHEMBL6703514 0.74 ALOX5AP (0.52) ALOX5APFEN1DYRK1A
SCHEMBL2372500 0.71 CSNK2A1 (0.47) SLC6A4TRPV1TLR8
SCHEMBL15913480 0.70 FEN1 (0.62) ALOX5APFEN1
SCHEMBL17718286 0.70 KMO (0.48) KMOMAP4K4
SCHEMBL15308476 0.70 KMO (0.51) KMOMAP4K4
SCHEMBL12925931 0.70 ALOX5AP (0.46) ALOX5APFEN1TLR9TLR8TLR7
SCHEMBL17657861 0.69 KMO (0.50) KMOMAP4K4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2951169-B1 FLAP MODULATORS JANSSEN PHARMACEUTICA NV (BE) 2019-08-28 EP disclosed
US-9926333-B2 Flap modulators JANSSEN PHARMACEUTICA NV (BE) 2018-03-27 US disclosed
US-20170327514-A1 FLAP MODULATORS JANSSEN PHARMACEUTICA NV (BE) 2017-11-16 US disclosed
US-9732093-B2 FLAP modulators JANSSEN PHARMACEUTICA NV (BE) 2017-08-15 US disclosed
US-20150368270-A1 FLAP MODULATORS JANSSEN PHARMACEUTICA NV (BE) 2015-12-24 US disclosed
EP-2951169-A1 FLAP MODULATORS Janssen Pharmaceutica, N.V. (BE) 2015-12-09 EP disclosed
US-20150252008-A1 FLAP MODULATORS JANSSEN PHARMACEUTICA NV (BE) 2015-09-10 US disclosed
US-9073876-B2 Flap modulators JANSSEN PHARMACEUTICA NV (BE) 2015-07-07 US disclosed
WO-2014121040-A1 FLAP MODULATORS JANSSEN PHARMACEUTICA NV (BE) 2014-08-07 WO disclosed
US-20140221310-A1 FLAP MODULATORS JANSSEN PHARMACEUTICA NV (US) 2014-08-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170327514-A1 FLAP MODULATORS FEN1, PGF, TBXA2R ALOX5AP 70/4885FEN1 1/4885DYRK1A 4599/4885
US-20140221310-A1 FLAP MODULATORS FEN1, PGF, PTGIS ALOX5AP 61/4885FEN1 1/4885DYRK1A 4594/4885
US-20150368270-A1 FLAP MODULATORS FEN1, PGF, TBXA2R ALOX5AP 70/4885FEN1 1/4885DYRK1A 4599/4885
US-20150252008-A1 FLAP MODULATORS FEN1, PGF, PTGIS ALOX5AP 61/4885FEN1 1/4885DYRK1A 4594/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.